Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
03:37:28 2026-06-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.0620 USD | -7.32% |
|
+13.76% | +10.91% |
| Market Cap | 22.86M 20.31M 18.96M 17.28M 32.59M 2.2B 32.9M 229M 88.91M 1.12B 85.84M 83.98M 3.61B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25.59M 22.74M 21.22M 19.34M 36.48M 2.46B 36.82M 257M 99.52M 1.26B 96.08M 93.99M 4.04B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -7.32% | ||
| 1 week | +13.76% | ||
| Current month | +8.58% | ||
| 1 month | +3.33% | ||
| 3 months | -10.14% | ||
| 6 months | +29.71% | ||
| Current year | +10.91% |
| 1 week | 0.05 |  | 0.07 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 2024-04-15 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 2012-05-14 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 2019-03-24 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2017-04-02 | |
John Lacey
BRD | Director/Board Member | 78 | 2018-04-26 |
Edward Pershing
CHM | Chairman | 73 | 2018-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/18/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 9/11/26 | Exercice | Chief Executive Officer | -13,216 | 0.1400% | ||
| 9/4/26 | Exercice | Chief Executive Officer | -11,328 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.32% | +13.76% | -18.10% | -26.19% | 22.86M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +79.01% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +35.99% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +748.97% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +31.45% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +111.69% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.01% | +3.18% | +31.19% | +28.44% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -12.10% | 24.34B | |
| Average | -0.57% | -0.53% | +45.75% | +114.55% | 39.06B | |
| Weighted average by Cap. | +0.39% | -0.84% | +57.09% | +139.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.47 0.88 59.33 0.89 6.19 2.4 30.33 2.32 2.27 97.34 | 0.34 0.3 0.28 0.25 0.48 32.31 0.48 3.37 1.31 16.52 1.26 1.23 53.01 |
| Net income | -4.76M -4.23M -3.95M -3.6M -6.79M -458M -6.85M -47.79M -18.52M -234M -17.88M -17.49M -751M | -5.43M -4.83M -4.5M -4.1M -7.74M -522M -7.81M -54.5M -21.12M -267M -20.39M -19.95M -857M |
| Net Debt | 2.88M 2.56M 2.39M 2.17M 4.1M 277M 4.14M 28.88M 11.19M 141M 10.8M 10.57M 454M | 2.73M 2.42M 2.26M 2.06M 3.89M 262M 3.92M 27.37M 10.61M 134M 10.24M 10.02M 430M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | $0.0544 | -.--% | 15,072 |
| 26-10-01 | $0.0544 | -4.73% | 425,782 |
| 26-09-30 | $0.0571 | -.--% | 5,300 |
| 26-09-29 | $0.0571 | -0.17% | 31,553 |
| 26-09-28 | $0.0572 | +4.95% | 75,060 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
